99 related articles for article (PubMed ID: 2695283)
1. The effect of islet-activating protein (IAP) of pertussis toxin on the spontaneous diabetic syndrome in the rat.
Bergada I; Colle E; Seemayer TA
Diabetes Res; 1989 Jun; 11(2):85-91. PubMed ID: 2695283
[TBL] [Abstract][Full Text] [Related]
2. Effect of islet-activating protein (IAP), purified from the culture medium of Bordetella pertussis, on the secretion of immunoreactive insulin and glucagon in normal, alloxan-treated, and depancreatized dogs.
Yoshida T; Nakamura Y; Nakano K; Kondo M
Diabetes; 1981 May; 30(5):430-4. PubMed ID: 6262169
[No Abstract] [Full Text] [Related]
3. Effect of islet-activating protein (IAP) upon insulin secretion from human pancreatic islets.
Araki Y; Yoshida T; Nakamura N; Koyama K; Nakamura Y; Nakano K; Kondo M
Endocrinol Jpn; 1981 Apr; 28(2):139-43. PubMed ID: 7030721
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of islet-activating protein on cultured rat pancreatic islets. Enhancement of insulin secretion, adenosine 3':5'-monophosphate accumulation and 45Ca flux.
Katada T; Ui M
J Biochem; 1981 Apr; 89(4):979-90. PubMed ID: 6166608
[TBL] [Abstract][Full Text] [Related]
5. Islet activating protein (IAP) derived from the culture supernatant fluid of Bordetella pertussis: effect on spontaneous diabetic rats.
Toyota T; Kakizaki M; Kimura K; Yajima M; Okamoto T; Ui M
Diabetologia; 1978 May; 14(5):319-23. PubMed ID: 348542
[TBL] [Abstract][Full Text] [Related]
6. Species differences in actions of islet-activating protein, pertussis toxin.
Yajima M; Okamoto T; Kurokawa S; Itoh A; Terashima A; Ui M
Jpn J Pharmacol; 1983 Jun; 33(3):583-91. PubMed ID: 6353019
[TBL] [Abstract][Full Text] [Related]
7. Pertussis toxin reverses the inhibition of insulin secretion caused by [Arg8]vasopressin in rat pancreatic islets.
Khalaf LJ; Taylor KW
FEBS Lett; 1988 Apr; 231(1):148-50. PubMed ID: 3282920
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic islet function in nondiabetic and diabetic BB rats.
Teruya M; Takei S; Forrest LE; Grunewald A; Chan EK; Charles MA
Diabetes; 1993 Sep; 42(9):1310-7. PubMed ID: 8349042
[TBL] [Abstract][Full Text] [Related]
9. Slow interaction of islet-activating protein with pancreatic islets during primary culture to cause reversal of alpha-adrenergic inhibition of insulin secretion.
Katada T; Ui M
J Biol Chem; 1980 Oct; 255(20):9580-8. PubMed ID: 6253447
[TBL] [Abstract][Full Text] [Related]
10. Effect of islet-activating protein (IAP) on long-term functional maintenance of cultured islets.
Taniguchi H; Tsutou A; Ejiri K; Tamagawa M; Ishihara K; Baba S
Kobe J Med Sci; 1982 Dec; 28(5-6):211-6. PubMed ID: 6763105
[No Abstract] [Full Text] [Related]
11. The effects of islet activating protein on oral glucose tolerance in the genetically obese fa/fa rat.
Proietto J; Rohner-Jeanrenaud F; Ionescu E; Jeanrenaud B
Metabolism; 1989 Apr; 38(4):338-42. PubMed ID: 2657321
[TBL] [Abstract][Full Text] [Related]
12. Enhanced glucose-induced insulin release and endogenous Ca2+ ionophoretic activity in neonatal rat islets following islet-activating protein.
Dunlop ME; Larkins RG
Biochem Biophys Res Commun; 1983 Apr; 112(2):684-92. PubMed ID: 6342618
[TBL] [Abstract][Full Text] [Related]
13. Effect of islet-activating protein (IAP) on glucagon release from isolated perifused rat islets.
Inoue K; Sako Y; Hisatomi A; Umeda F; Nawata H
Fukuoka Igaku Zasshi; 1989 Sep; 80(9):441-5. PubMed ID: 2572523
[TBL] [Abstract][Full Text] [Related]
14. Effect of islet activating protein on glucose tolerance, insulin secretion and insulin responsiveness in the NZO mouse.
Re CA; Veroni MC; Larkins RG
Diabetologia; 1984 Apr; 26(4):304-9. PubMed ID: 6376239
[TBL] [Abstract][Full Text] [Related]
15. Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate.
Tominaga M; Komiya I; Johnson JH; Inman L; Alam T; Moltz J; Crider B; Stefan Y; Baetens D; McCorkle K
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9749-53. PubMed ID: 3540950
[TBL] [Abstract][Full Text] [Related]
16. Plasma from BB/Wor rats increases insulin secretion by perfused rat pancreas.
Driscoll HK; Gottlieb PA; Mordes JP; Matschinsky FM; Rossini AA
Endocrinology; 1990 Feb; 126(2):1241-9. PubMed ID: 2404744
[TBL] [Abstract][Full Text] [Related]
17. Time course of islet cell antibodies in diabetic and nondiabetic BB rats.
Laborie C; Sai P; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Poussier P; Marliss EB; Assan R
Diabetes; 1985 Sep; 34(9):904-10. PubMed ID: 3896899
[TBL] [Abstract][Full Text] [Related]
18. Prospective investigations of long-term normoglycaemic BB/OK-rats: serial determination of glucose tolerance, insulitis, B-cell volume density and pancreatic insulin content.
Hahn HJ; Lucke S; Klöting I; Besch W
Exp Clin Endocrinol; 1991; 98(3):185-92. PubMed ID: 1778238
[TBL] [Abstract][Full Text] [Related]
19. Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model.
Tamura M; Nogimori K; Murai S; Yajima M; Ito K; Katada T; Ui M; Ishii S
Biochemistry; 1982 Oct; 21(22):5516-22. PubMed ID: 6293544
[TBL] [Abstract][Full Text] [Related]
20. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat.
Andersen HU; Mandrup-Poulsen T; Egeberg J; Helqvist S; Nerup J
Acta Endocrinol (Copenh); 1989 Jan; 120(1):92-8. PubMed ID: 2643251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
